Nrx Pharmaceuticals Inc (NRXP)

$1.41 0.07 (4.73%)

16:00 EDT NRXP Stock Quote Delayed 30 Minutes

NRXP Stock Alert: The Covid-19 News Lifting NRx Pharmaceuticals Today

By Samuel O'Brient, InvestorPlace Financial News Writer Jan 5, 2022

News of a potential Covid-19 treatment breakthrough has NRXP stock rising today. Here's what you need to know about this FDA filing.

RLFTF Stock Alert: What Is Going on With Relief Therapeutics Today?

NRXP Stock Alert: What Is Going on With NRx Pharmaceuticals Today?

NRXP Stock Surges on Latest Covid-19 Update From NRx Pharmaceuticals

Volume:

Previous Close -

Market Cap -

PE Ratio -

EPS -

Volume (Avg. Vol.) 281,210

Day's Range $1.35 - $1.45

52-Week Range $1.15 - $26.24

Dividend & Yield N/A (N/A)

NRXP Stock Predictions, Articles, and Nrx Pharmaceuticals Inc News

From InvestorPlace
From the Web

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday

By William White, InvestorPlace Writer Nov 29, 2021

I hope you got your rest out over the holiday weekend because we're starting off Monday with the biggest pre-market stock movers!

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday

By William White, InvestorPlace Writer Nov 3, 2021

Good morning, trader! We're starting the day off right with a dive into the biggest pre-market stock movers for Wednesday!

NRXP Stock: The Critical Covid-19 Trial Results That Have NRx Pharma Rocketing Higher

By William White, InvestorPlace Writer Oct 14, 2021

NRX Pharmaceuticals (NRXP) stock is surging higher on Thursday thanks to recent results from a clinical trial of its Covid-19 treatment.

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday

By William White, InvestorPlace Writer Oct 13, 2021

We're at the halfway point of the trading week and that has us checking in on the biggest pre-market stock movers for Wednesday!

NRXP Stock Is Soaring Today Thanks to This Big FDA Catalyst

By Samuel O'Brient, InvestorPlace Financial News Writer Oct 12, 2021

NRx Pharmaceuticals got some good news from the FDA and its shareholders are happy as NRXP stock enjoys a day of impressive gains.

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday

By William White, InvestorPlace Writer Sep 7, 2021

It's been a long holiday weekend but we're getting right back into the swing of things with a look at the pre-market stock movers for today!

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday

By William White, InvestorPlace Writer Aug 24, 2021

Good morning, investor! We're getting ready for another busy day of trading with a dive into the biggest pre-market stock movers for Tuesday.

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday

By William White, InvestorPlace Writer Jul 23, 2021

We're gearing up for one final day of trading this week with a breakdown of the biggest pre-market stock movers for Friday!

NRXP Stock: This Covid-19 Treatment Could Prime NRx Pharmaceuticals for Big Gains

By Brenden Rearick, InvestorPlace Financial News Writer Jul 22, 2021

NRXP stock came to investors' attention last year with its Covid-19 treatment. Now, it's looking like a great play as it eyes up EUA.

NRXP Stock: The ‘Cykotine Storm’ Drug News Sending NRx Pharma Shares Soaring

By Nick Clarkson, Web Editor Jul 19, 2021

Shares of NRXP stock are taking off on Monday after the pharmaceutical company reported positive results regarding its Zyesami trial.

BRPA Stock: 14 Things to Know About Big Rock Partners and the NeuroRx SPAC Merger

By Sarah Smith, Editor, Today's Market Dec 22, 2020

BRPA stock is shooting higher as investors process news that Big Rock Partners will take NeuroRx public. Here's what to know.

12 Health Care Stocks Moving In Friday's Pre-Market Session

From Benzinga May 20, 2022

Earnings Scheduled For May 16, 2022

From Benzinga May 16, 2022

Companies Reporting Before The Bell • AcelRx Pharmaceuticals (NASDAQ:ACRX) is estimated to report quarterly loss at $0.06 per share on revenue of $550.00 thousand.

NRx Pharmaceuticals Again Requests For FDA Breakthrough Therapy Status For COVID-19 Therapy

From Benzinga Apr 21, 2022

NRx Pharmaceuticals Raises $25M Via Equity To Support Its Pipeline Development

From Benzinga Jan 31, 2022

NRx Pharmaceuticals (NASDAQ: NRXP) has announced the private placement of 7.8 million shares priced at a premium to market under Nasdaq rule, for

Stocks That Hit 52-Week Lows On Thursday

From Benzinga Apr 21, 2022

On Thursday, 236 companies hit new 52-week lows.

53 Biggest Movers From Yesterday

From Benzinga Apr 1, 2022

Gainers Longeveron Inc. (NASDAQ: LGVN) shares jumped 105.4% to close at $13.80 on Thursday after the company announced the publication of results from a Phase 1 trial testing...

Nrx Pharmaceuticals Inc (NRXP)

NRXP Stock Alert: The Covid-19 News Lifting NRx Pharmaceuticals Today

RLFTF Stock Alert: What Is Going on With Relief Therapeutics Today?

NRXP Stock Alert: What Is Going on With NRx Pharmaceuticals Today?

NRXP Stock Surges on Latest Covid-19 Update From NRx Pharmaceuticals

11 Best Stocks to Buy for 2022

Louis Navellier's Total Grade

Is ? a BUY?

Louis Navellier's Total Grade

Louis Navellier's Total Grade

Fundamental Grade

Quantitative Grade

Nrx Pharmaceuticals Inc (NRXP)

11 Best Stocks to Buy for 2022

Louis Navellier's Total Grade

Is ? a BUY?

Louis Navellier's Total Grade

Louis Navellier's Total Grade

Fundamental Grade

Quantitative Grade

NRXP Stock Predictions, Articles, and Nrx Pharmaceuticals Inc News

Subscriber Sign in